You either are clueless or deliberately misleading about the pathway for exceptions to adequate and well controlled studies. I believe you and others are deliberately misleading because of the number of times this pathway has been mentioned by me starting with one of my earliest posts on ihub almost 10 years ago. Feel free to read and accept what has been shared many times before or just continue to mislead along with your buddies. Best wishes.
Market Data 
Markets 
AI
